Abbott Diabetes Care received US Food and Drug Administration clearance for its FreeStyle Libre 3 continuous glucose monitor system, the company announced prior to market opening on 31 May.
FDA Clears Abbott’s Libre 3
Abbott’s FreeStyle Libre 3 system will soon be available in the US. It is 70% smaller than the Libre 2 while also providing better accuracy.
